NCT06158776 is a clinical trial in Rectal Adenoma, sponsored by Aiyin Li.

Who is sponsoring NCT06158776?

NCT06158776 is sponsored by Aiyin Li.

What condition does NCT06158776 study?

NCT06158776 studies Rectal Adenoma.

Is NCT06158776 still recruiting?

NCT06158776 is currently completed. Last updated 6 December 2023.

Last reviewed 2023-12-06 · How we verify

NCT06158776

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Predicting Rectal Adenoma With Canceration and Investigating Mechanism Based on Multimodal MRI and Biochemical Model

Completed Last updated 6 December 2023

What this trial tests

trial in Rectal Adenoma in 100 participants. Completed in 15 June 2022.

Timeline

1 January 2022

Primary endpoint
31 May 2022

15 June 2022

Quick facts

Lead sponsor	Aiyin Li
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 January 2022
Primary completion	31 May 2022
Estimated completion	15 June 2022
Sites	1 location across China

Conditions studied

Rectal Adenoma — all drugs for Rectal Adenoma →

Sponsor

Aiyin Li

Who can join

Eligibility, any sex, with Rectal Adenoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this retrospective study is to establish a diagnostic model for rectal adenoma canceration. The model will include multimodal comprehensive HR-T2WI morphological score, IVIM functional imaging and radiomics features, and clinical indicators such as tumor markers, serum Gelsolin protein and peripheral blood inflammatory cell ratio. It can be to provide accurate diagnostic information for patients before surgery, which is of great value for formulating personalized treatment plans and improving the prognosis of patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06158776 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aiyin Li
Last refreshed: 6 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06158776.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing